Verition Fund Management’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
Other funds holding TWST
Verition Fund Management's TWST Position: Q3 2026 in Review
Verition Fund Management sold out of Twist Bioscience (TWST) in Q3 2026, closing a stake of 37,369 shares — an estimated $3.84M sold.
Verition Fund Management first reported a position in TWST in Q1 2023 and held it in 7 quarters. The position peaked at $3.84M in Q2 2026. 429 funds tracked by Wall St. Rank hold TWST as of Q3 2026.
- Verition Fund Management reported no remaining Twist Bioscience position as of Q3 2026 after selling out during the quarter.
- Verition Fund Management sold 37,369 Twist Bioscience shares in Q3 2026, an estimated $3.84M.
- Verition Fund Management first reported a position in Twist Bioscience in Q1 2023 and held it in 7 quarters.
- Verition Fund Management's Twist Bioscience position peaked at $3.84M in Q2 2026.
- 429 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2026.
Based on Verition Fund Management's 13F filing for Q3 2026, filed 13 Nov 2026.